Hosted by Orrick, this year’s One Nucleus satellite event will focus on one of the key topics of the moment with impacts on the FDA of recent announcements to play out, the speaker and Q&A will discuss what potential outcomes could mean for growing life science companies in terms of regulatory approval timescales and advice and the consequential impacts on the required financing strategy to underpin their growth.

Agenda:
07.30  Arrival & Breakfast
07.50  Welcome
           Angus McQuilken, Business Development Associate – Life Sciences, Orrick 
08.00  An Update on FDA Changes and Potential Impact
          Georgia Ravitz, Partner, Orrick 
08.20  Fireside Chat and Q&A moderated by Tony Jones, CEO, One Nucleus 
09.00  Close

Registration: This event is free to attend and by invite only. To request an invitation, please email Tony Jones at tony@onenucleus.com to secure your place whilst capacity remains.

About our hosts:

Orrick is a global law firm focused on delivering innovative solutions for four sectors: Technology & Innovation, Energy & Infrastructure, Finance and Life Sciences & HealthTech.

Orrick has a team of more than 40 tech and life sciences lawyers in its Boston office, which launched in 2019. Last summer, the firm added a 7-lawyer FDA and healthcare regulatory team, based in Boston and Washington, DC, focused on venture-backed companies.